How blind was the patient blind in AMIS?

[1]  M. Weinberger,et al.  The value of maintenance theophylline in steroid-dependent asthma. , 1981, The New England journal of medicine.

[2]  Sixty Plus Reinfarction Study Research Group.  A DOUBLE-BLIND TRIAL TO ASSESS LONG-TERM ORAL ANTICOAGULANT THERAPY IN ELDERLY PATIENTS AFTER MYOCARDIAL INFARCTION , 1980, The Lancet.

[3]  W. Buchanan,et al.  Continued use of non-steroidal anti-inflammatory drugs: an index of clinical efficacy. , 1978, British journal of clinical pharmacology.

[4]  S. Zifferblatt,et al.  A psychological perspective for double‐blind trials , 1978, Clinical pharmacology and therapeutics.

[5]  R. Rose,et al.  Therapeutic effect of vitamin C. A co-twin control study. , 1977, JAMA.

[6]  M. Sheard,et al.  AN EVALUATION OF THE DOUBLE‐BLIND DESIGN IN A STUDY COMPARING LITHIUM CARBONATE WITH PLACEBO , 1976, Acta psychiatrica Scandinavica.

[7]  P. Corey,et al.  Winter illness and vitamin C: the effect of relatively low doses. , 1975, Canadian Medical Association journal.

[8]  T C Chalmers,et al.  Ascorbic acid for the common cold. A prophylactic and therapeutic trial. , 1975, JAMA.

[9]  G. Beaton,et al.  The effect on winter illness of large doses of vitamin C. , 1974, Canadian Medical Association journal.

[10]  R. Fieve,et al.  Letter: How blind is the double-blind?: an assessment in a lithium-prophylaxis study. , 1974, Lancet.

[11]  G. Beaton,et al.  Vitamin C and the common cold: a double-blind trial. , 1972, Canadian Medical Association journal.

[12]  L. Pauling.  Ascorbic acid and the common cold. , 1971, The American journal of clinical nutrition.

[13]  R. Prineas.  COMMON PROBLEMS IN CLINICAL TRIALS , 1971, The Medical journal of Australia.

[14]  A. Burger.  Psychopharmacology. A Review of Progress, 1957-1967 , 1969 .

[15]  A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. , 1980, JAMA.